脊髓髓内转移瘤:单机构生存与结局回顾分析
本文回顾性分析1997至2016年间单机构收治的70例(86个病灶)脊髓髓内转移瘤患者,比较不同治疗方式及影响生存与神经结局的因素。中位生存期为104.5天,孤立转移灶患者生存长于多发灶(3.6 vs 2.2个月,p=0.01);孤立病灶且无脑转移者手术切除与更长生存相关(6 vs 3个月,p=0.02)。作者认为髓内转移可能较全身转移负荷对总生存影响更大。
要点
- 胸髓最常见(50%),其次颈髓(34%)和脊髓圆锥(14%)。
- 孤立转移灶生存长于多发灶(3.6 vs 2.2个月,p=0.01)。
- 孤立灶无脑转移者手术切除与更长生存相关(6 vs 3个月,p=0.02)。
核心结论
- 脊髓髓内转移瘤患者总体生存仍差。
- 作者认为对经过选择的部分患者,手术处理可能有助于改善生存与神经结局。
- 作者认为髓内转移对总生存的作用可能大于全身转移负荷。
研究设计与样本
- 单机构回顾性病例系列,分析1997至2016年间确诊的脊髓髓内转移瘤患者病历。
- 共纳入70例患者、86个病灶。
- 比较不同处理方式及影响生存与神经结局的因素。
主要发现
- 病灶位于胸髓者占50%,颈髓34%,脊髓圆锥14%。
- 诊断时平均年龄55.6 ± 10.6岁,女性占60%(n=42)。
- 中位生存期104.5天(范围1–888天)。
- 23例(33%)接受保守处理,39例(56%)接受姑息性放疗,8例(11%)接受手术,其中1例仅接受活检。
- 年龄、性别、合并脑转移及其他全身转移不影响生存;孤立转移灶患者生存长于多发灶(3.6 vs 2.2个月,p=0.01);孤立病灶无脑转移者手术切除与显著更长生存相关(6 vs 3个月,p=0.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Intramedullary spinal cord metastases (ISCMs) are rare lesions affecting the spinal cord in patients with disseminated malignancy. Today, due to increased survival, these lesions are more frequently diagnosed. Literature on survival and neurologic outcomes is sparse. Herein, we describe a single institutional case series on ISCMs reported to date in the English literature. METHODS: We retrospectively analyzed the medical records of patients diagnosed with intramedullary metastatic lesions at our institution between 1997 and 2016. We analyzed different approaches to management and factors influencing survival and neurologic outcomes. RESULTS: A total of 70 patients (86 lesions) were analyzed. Most lesions were found in thoracic spinal cord (50%) followed by cervical (34%) and conus medullaris (14%). Mean age at diagnosis was 55.6 ± 10.6 years with 60% (n = 42) being females. Median survival was 104.5 days (range 1-888 days). Twenty-three patients (33%) received conservative management, 39 (56%) received palliative radiotherapy, whereas 8 (11%) underwent surgery with one patient receiving only a biopsy. Age, sex, presence of concomitant brain and other systemic metastasis didn't influence survival. Patients with solitary metastases had longer survival compared to multiple lesions (3.6 vs. 2.2 months, p = 0.01). In patients with solitary lesions without brain metastasis, surgical resection was associated with significantly longer survival (6 months vs. 3 months, p = 0.02). CONCLUSION: The overall survival in patients with intramedullary metastasis remains poor. Surgical management may contribute to improved survival and neurologic outcomes in selected patients. Intramedullary metastasis may have a greater role on overall survival compared to systemic metastatic burden.
引用
- Goyal A, Yolcu Y, Kerezoudis P, et al. Intramedullary spinal cord metastases: an institutional review of survival and outcomes. J Neurooncol. 2019. PMID: 30656530. doi:10.1007/s11060-019-03105-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。